Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Smooth | 9 | 2021 | 931 | 1.240 |
Why?
|
| Myosin-Light-Chain Kinase | 7 | 2016 | 104 | 1.080 |
Why?
|
| Cartilage, Articular | 2 | 2022 | 1104 | 0.930 |
Why?
|
| Chloride Channels | 2 | 2016 | 221 | 0.860 |
Why?
|
| Musculoskeletal Physiological Phenomena | 1 | 2022 | 31 | 0.820 |
Why?
|
| Taste | 2 | 2013 | 190 | 0.750 |
Why?
|
| Proteoglycans | 2 | 2022 | 809 | 0.750 |
Why?
|
| Cyclic AMP Response Element-Binding Protein A | 1 | 2021 | 21 | 0.750 |
Why?
|
| Bronchi | 3 | 2013 | 850 | 0.680 |
Why?
|
| Chondrocytes | 2 | 2022 | 800 | 0.650 |
Why?
|
| Calcium Signaling | 4 | 2021 | 738 | 0.590 |
Why?
|
| Anal Canal | 2 | 2021 | 376 | 0.580 |
Why?
|
| Muscle Contraction | 8 | 2021 | 1209 | 0.520 |
Why?
|
| Bronchial Hyperreactivity | 2 | 2017 | 301 | 0.510 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2016 | 185 | 0.480 |
Why?
|
| Muscle Hypotonia | 1 | 2016 | 166 | 0.470 |
Why?
|
| Calcium Channels, L-Type | 1 | 2016 | 244 | 0.470 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2021 | 703 | 0.440 |
Why?
|
| Fecal Incontinence | 1 | 2016 | 246 | 0.430 |
Why?
|
| Muscle Relaxation | 1 | 2012 | 138 | 0.390 |
Why?
|
| Myocytes, Cardiac | 2 | 2019 | 1682 | 0.340 |
Why?
|
| Bronchodilator Agents | 1 | 2013 | 518 | 0.320 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2017 | 1248 | 0.310 |
Why?
|
| Myosin Light Chains | 4 | 2019 | 122 | 0.290 |
Why?
|
| Airway Obstruction | 1 | 2012 | 672 | 0.280 |
Why?
|
| Patch-Clamp Techniques | 2 | 2016 | 927 | 0.200 |
Why?
|
| Calcium | 6 | 2021 | 5792 | 0.190 |
Why?
|
| Heart | 1 | 2014 | 4447 | 0.190 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2021 | 134 | 0.180 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2021 | 71 | 0.180 |
Why?
|
| Cell Proliferation | 2 | 2019 | 10486 | 0.170 |
Why?
|
| Phosphorylation | 7 | 2021 | 8317 | 0.160 |
Why?
|
| Gastrointestinal Motility | 2 | 2013 | 235 | 0.160 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2019 | 243 | 0.160 |
Why?
|
| Asthma | 3 | 2017 | 6293 | 0.150 |
Why?
|
| Cytokinesis | 1 | 2019 | 170 | 0.150 |
Why?
|
| Gene Expression Regulation | 3 | 2022 | 11932 | 0.150 |
Why?
|
| Cell Differentiation | 1 | 2014 | 11684 | 0.140 |
Why?
|
| Niflumic Acid | 1 | 2016 | 9 | 0.140 |
Why?
|
| Defecation | 2 | 2016 | 191 | 0.140 |
Why?
|
| Bethanechol | 1 | 2016 | 12 | 0.130 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2014 | 1493 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2021 | 1246 | 0.130 |
Why?
|
| Nifedipine | 1 | 2016 | 220 | 0.130 |
Why?
|
| Cattle | 1 | 2021 | 3819 | 0.120 |
Why?
|
| Animals | 18 | 2021 | 169335 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 6 | 2019 | 22379 | 0.120 |
Why?
|
| Calcium Channels | 1 | 2017 | 624 | 0.110 |
Why?
|
| Membrane Potentials | 1 | 2016 | 1090 | 0.100 |
Why?
|
| Mice | 14 | 2021 | 82072 | 0.100 |
Why?
|
| Reperfusion Injury | 1 | 2019 | 1036 | 0.100 |
Why?
|
| Binding Sites | 1 | 2021 | 6023 | 0.100 |
Why?
|
| Vasoconstriction | 2 | 2014 | 593 | 0.100 |
Why?
|
| Intestines | 2 | 2013 | 1911 | 0.100 |
Why?
|
| Chloroquine | 1 | 2013 | 276 | 0.090 |
Why?
|
| Urinary Bladder | 2 | 2014 | 1162 | 0.090 |
Why?
|
| Myosin-Light-Chain Phosphatase | 3 | 2014 | 21 | 0.090 |
Why?
|
| Muscle Tonus | 1 | 2009 | 82 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 1 | 2021 | 5801 | 0.080 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2011 | 301 | 0.080 |
Why?
|
| Mice, Knockout | 7 | 2019 | 14484 | 0.070 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2010 | 572 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2019 | 3592 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 9565 | 0.060 |
Why?
|
| Phosphoproteins | 2 | 2014 | 2452 | 0.060 |
Why?
|
| Cells, Cultured | 1 | 2021 | 19023 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2012 | 5033 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2012 | 6236 | 0.060 |
Why?
|
| Trachea | 1 | 2009 | 1095 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2012 | 4148 | 0.050 |
Why?
|
| Cerebellum | 1 | 2010 | 1522 | 0.050 |
Why?
|
| Mesenteric Arteries | 2 | 2014 | 178 | 0.050 |
Why?
|
| Blood Pressure | 3 | 2014 | 8544 | 0.050 |
Why?
|
| Signal Transduction | 4 | 2017 | 23653 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 11116 | 0.040 |
Why?
|
| Reflex | 1 | 2021 | 375 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 3612 | 0.040 |
Why?
|
| Nitric Oxide | 2 | 2021 | 2149 | 0.040 |
Why?
|
| Propranolol | 1 | 2019 | 493 | 0.040 |
Why?
|
| Phenotype | 4 | 2019 | 16731 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2012 | 18354 | 0.030 |
Why?
|
| Muscle Cells | 1 | 2017 | 195 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 2017 | 1309 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 2019 | 773 | 0.030 |
Why?
|
| Electrophysiological Phenomena | 1 | 2017 | 310 | 0.030 |
Why?
|
| Paracrine Communication | 1 | 2017 | 278 | 0.030 |
Why?
|
| Hypertension | 2 | 2014 | 8617 | 0.030 |
Why?
|
| Potassium | 2 | 2009 | 1315 | 0.030 |
Why?
|
| Male | 8 | 2019 | 365203 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2019 | 2683 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2019 | 1243 | 0.030 |
Why?
|
| Respiratory Mucosa | 1 | 2017 | 439 | 0.030 |
Why?
|
| Female | 8 | 2019 | 397515 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2019 | 1036 | 0.030 |
Why?
|
| Desoxycorticosterone | 1 | 2011 | 46 | 0.020 |
Why?
|
| Potassium Chloride | 1 | 2011 | 229 | 0.020 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2010 | 125 | 0.020 |
Why?
|
| Vasodilation | 1 | 2014 | 967 | 0.020 |
Why?
|
| Point Mutation | 1 | 2014 | 1596 | 0.020 |
Why?
|
| Intermediate Filament Proteins | 1 | 2010 | 262 | 0.020 |
Why?
|
| Calmodulin | 1 | 2009 | 241 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 2014 | 1165 | 0.020 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2010 | 279 | 0.020 |
Why?
|
| Airway Resistance | 1 | 2009 | 407 | 0.020 |
Why?
|
| Peristalsis | 1 | 2008 | 60 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2010 | 564 | 0.020 |
Why?
|
| Acetylcholine | 1 | 2009 | 629 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 2011 | 657 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 4528 | 0.020 |
Why?
|
| Morphogenesis | 1 | 2010 | 747 | 0.020 |
Why?
|
| Nephrectomy | 1 | 2011 | 949 | 0.020 |
Why?
|
| Humans | 5 | 2019 | 768970 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2008 | 902 | 0.020 |
Why?
|
| Cell Line | 1 | 2019 | 15604 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2009 | 967 | 0.020 |
Why?
|
| Genotype | 2 | 2011 | 13048 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2010 | 1179 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2017 | 3080 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2019 | 12806 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2893 | 0.010 |
Why?
|
| Muscle Strength | 1 | 2008 | 641 | 0.010 |
Why?
|
| Rats | 1 | 2019 | 23786 | 0.010 |
Why?
|
| Eating | 1 | 2008 | 1542 | 0.010 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2009 | 1535 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 10765 | 0.010 |
Why?
|
| Cell Movement | 1 | 2010 | 5216 | 0.010 |
Why?
|
| Time Factors | 2 | 2011 | 40261 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2010 | 4413 | 0.010 |
Why?
|
| Pregnancy | 1 | 2019 | 30265 | 0.010 |
Why?
|
| Neurons | 1 | 2010 | 9519 | 0.010 |
Why?
|
Concepts
(130)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(5)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_